Correlation Between Phio Pharmaceuticals and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Edgewise Therapeutics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Edgewise Therapeutics.
Diversification Opportunities for Phio Pharmaceuticals and Edgewise Therapeutics
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Phio and Edgewise is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Edgewise Therapeutics
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Edgewise Therapeutics. In addition to that, Phio Pharmaceuticals is 2.96 times more volatile than Edgewise Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 944.00 in Edgewise Therapeutics on November 18, 2024 and sell it today you would earn a total of 1,595 from holding Edgewise Therapeutics or generate 168.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Edgewise Therapeutics
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Edgewise Therapeutics |
Phio Pharmaceuticals and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Edgewise Therapeutics
The main advantage of trading using opposite Phio Pharmaceuticals and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets |